AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siakotos, A. N.
Right arrow Articles by Bucana, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siakotos, A. N.
Right arrow Articles by Bucana, C.
Agricola
Right arrow Articles by Siakotos, A. N.
Right arrow Articles by Bucana, C.

American Journal of Clinical Nutrition, Vol 27, 1152-1157, Copyright © 1974 by The American Society for Clinical Nutrition, Inc.

Blood levels of agr-tocopherol in a disorder of lipid peroxidation: Batten's disease

A. N. Siakotos Ph.D.1, N. Koppang D.V.M.1, S. Youmans B.S.1, and C. Bucana Ph.D.1

1 From the Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202

Batten's disease is characterized by the onset of progressive mental regression and seizures. The brain cells of patients with this disease show the accumulation of large masses of a lipopigment, ceroid. Similar accumulations have been observed in the brain of a genetic strain of English setters. Previous studies by our laboratory have established that the accumulated lipopigment, ceroid, is clearly different from "age" pigment, or lipofuscin, in a number of parameters, although some similarities exist between the two lipopigments. Zeman and others have proposed that this group of disorders is the result of a massive peroxidation of essential fatty acids with the accumulation of large masses of lipid polymers in the form of lipopigments. Since the proposed biological role of agr-tocopherol is that of an antioxidant, this compound has been utilized in experimental therapeutic approaches with patients affected with Batten's disease. At this time, the standard treatment for this group of disorders is the administration of a mixture of vitamin E, ascorbic acid, methionine, and butylated hydroxylated toluene as originally proposed by Tappel. Patients on this therapeutic regimen have shown some improvement. Our approach to this problem was to investigate the blood and tissue levels of agr-tocopherol in this disorder. Early studies suggested that blood agr-tocopherol levels were below normal values. However, a study on a large number of samples from both human patients and dogs with a similar disease clearly established that blood and tissue levels of agr-tocopherol are significantly higher than normal age-matched controls. Obviously this "peroxidative disorder" progresses in spite of an ample supply of the biological antioxidant, agr-tocopherol. If agr-tocopherol is a significant factor in the inhibition of peroxidative damage, then agr-tocopherol may not act exclusively as an antioxidant as has been proposed by a number of investigators.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
J. L. Griffin, D. Muller, R. Woograsingh, V. Jowatt, A. Hindmarsh, J. K. Nicholson, and J. E. Martin
Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics
Physiol Genomics, December 3, 2002; 11(3): 195 - 203.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by The American Society for Nutrition